Aplagon
  • ABOUT US
    • Management Team
    • Scientific Advisory Board
    • Investors
  • PRODUCTS
  • PARTNERING
  • NEWS & EVENTS
    • Publications
  • CONTACT US
  • Menu

Latest news

  • First Patient Treated in First Clinical Study for Aplagon’s APAC7th June 2022
  • ISTH 202227th April 2022
  • LSX World 202227th April 2022

Website by Instinctif Partners

Aplagon Oy
Biomedicum Helsinki 2A
Tukholmankatu 8 A, 00290 Helsinki, Finland

Scroll to top